Yonatan Malca - 02 Jan 2023 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli , Attorney-in-Fact
Issuer symbol
ENTX
Transactions as of
02 Jan 2023
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 15:08:05 UTC
Previous filing
18 Jan 2022
Next filing
03 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTX Stock Option (right to buy) Award $0 +89,041 $0.000000 89,041 02 Jan 2023 Ordinary Shares, par value NIS 0.0000769 per share 89,041 $0.7300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest ratably on a quarterly basis over a one-year period that commenced on January 2, 2023.